Ethanol modulates mammalian circadian clock phase resetting through extrasynaptic GABA receptor activation.
Ethanol modulates the actions of multiple neurotransmitter systems, including GABA. However, its enhancing effects on GABA signaling typically are seen only at high concentrations. In contrast, although GABA is a prominent neurotransmitter in the circadian clock of the suprachiasmatic nucleus (SCN), we see ethanol modulation of clock phase resetting at low concentrations (<50 mM). A possible explanation is that ethanol enhances GABAergic signaling in the SCN through activating GABA(A) receptors that contain the delta subunit (GABA(Adelta) receptors), which are sensitive to low ethanol concentrations. Therefore, we investigated whether ethanol acts on GABA(Adelta) receptors in the SCN. Here we show that acute application of the GABA(Adelta) receptor antagonist, RO15-4513, to mouse hypothalamic slices containing the SCN prevents ethanol inhibition of nighttime glutamate-induced (photic-like) phase delays of the circadian clock. Diazepam, which enhances activity of GABA(A) receptors containing the gamma subunit (GABA(Agamma) receptors), does not modulate these phase shifts. Moreover, we find that RO15-4513 prevents ethanol enhancement of daytime serotonergic (non-photic) phase advances of the circadian clock. Furthermore, diazepam phase-advances the SCN circadian clock when applied alone in the daytime, while ethanol has no effect by itself at that time. These data support the hypothesis that ethanol acts on GABA(Adelta) receptors in the SCN to modulate photic and non-photic circadian clock phase resetting. They also reveal distinct modulatory roles of different GABA(A) receptor subtypes in circadian clock phase regulation.
McElroy
B
B
Department Biochemistry and Cellular and Molecular Biology, University of Tennessee, Knoxville, TN 37996, USA.
Zakaria
A
A
Glass
J D
JD
Prosser
R A
RA
D000818:Animals; D001386:Azides / Q000008:administration & dosage / Q000494:pharmacology; D001569:Benzodiazepines / Q000008:administration & dosage / Q000494:pharmacology; D002492:Central Nervous System Depressants / Q000494:pharmacology*; D002940:Circadian Rhythm / Q000187:drug effects* / Q000502:physiology*; D003975:Diazepam / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D000431:Ethanol / Q000494:pharmacology*; D018756:GABA Antagonists / Q000008:administration & dosage / Q000494:pharmacology; D018757:GABA Modulators / Q000494:pharmacology; D058787:GABA-A Receptor Antagonists; D018698:Glutamic Acid / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D017440:Photoperiod; D011963:Receptors, GABA-A / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism; D013493:Suprachiasmatic Nucleus / Q000187:drug effects / Q000502:physiology
D001386:Azides; D002492:Central Nervous System Depressants; D018756:GABA Antagonists; D018757:GABA Modulators; D058787:GABA-A Receptor Antagonists; D011963:Receptors, GABA-A; D001569:Benzodiazepines; D012701:Serotonin; D000431:Ethanol; D018698:Glutamic Acid; C042957:Ro 15-4513; D003975:Diazepam
Am J Physiol Regul Integr Comp Physiol. 2009 May;296(5):R1606-12
19244580
Neurosci Lett. 1993 Dec 12;163(2):177-81
8309627
Am J Physiol Regul Integr Comp Physiol. 2009 Feb;296(2):R411-8
19073899
Alcohol. 2007 May;41(3):155-62
17521845
J Neurosci. 2008 Nov 12;28(46):11890-9
19005054
Brain Res. 1995 Nov 27;700(1-2):142-56
8624705
J Biol Rhythms. 1993;8 Suppl:S11-5
7903876
Brain Res Mol Brain Res. 1995 Feb;28(2):239-50
7723623
Nat Neurosci. 2007 Jan;10(1):40-8
17159992
J Biol Rhythms. 1996 Jun;11(2):137-44
8744241
Alcohol. 2007 May;41(3):187-99
17521847
Brain Res. 1985 Jan 28;325(1-2):362-5
3978427
Neuroreport. 2003 Mar 24;14(4):641-4
12657903
Neuropharmacology. 2009 Jan;56(1):141-8
18760291
Brain Res. 1997 Jun 13;759(2):181-9
9221935
Synapse. 2005 Jan;55(1):52-7
15515007
J Biol Rhythms. 1993 Spring;8(1):1-16
8490207
Neuron. 2000 Jan;25(1):123-8
10707977
Trends Neurosci. 2004 May;27(5):262-9
15111008
Brain Res. 2003 Mar 14;966(1):110-5
12646314
Neuroscience. 2008 Mar 27;152(3):837-48
18313227
J Neurosci. 1998 Mar 1;18(5):1693-703
9464994
Alcohol. 2007 May;41(3):211-21
17591544
Eur J Neurosci. 2006 Aug;24(4):1109-16
16930436
Pharmacol Ther. 2006 Sep;111(3):533-54
16427127
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15218-23
14625373
Neurosci Lett. 1994 Jan 17;166(1):81-4
8190363
Brain Res Bull. 1980 Jul-Aug;5(4):405-14
7407637
Neurosci Lett. 1993 Sep 17;160(1):45-8
8247331
J Neurophysiol. 2002 May;87(5):2624-8
11976398
J Neurosci. 2004 Sep 22;24(38):8379-82
15385620
Nat Neurosci. 2005 Mar;8(3):339-45
15696164
FEBS Lett. 1993 Jun 14;324(2):140-2
8389719
J Neurosci. 2004 Apr 14;24(15):3746-51
15084654
J Neurosci. 1989 Mar;9(3):1073-81
2538580
Mol Pharmacol. 1996 Mar;49(3):567-79
8643098
J Pharmacol Exp Ther. 2006 Mar;316(3):1360-8
16272217
Br J Pharmacol. 2008 May;154(2):299-315
18311194
J Biol Rhythms. 2008 Feb;23(1):16-25
18258754
Neuroscience. 2006 Oct 13;142(2):547-55
16876330
Neurosci Lett. 2001 Sep 14;310(2-3):178-82
11585596
J Comp Neurol. 1990 Dec 22;302(4):1019-37
2081813
Neuroscience. 2003;118(4):909-23
12732237
Br J Pharmacol. 2008 May;154(2):288-98
18278063
J Biol Rhythms. 1999 Feb;14(1):47-53
10036992
Nature. 1997 Sep 25;389(6649):385-9
9311780
Brain Res. 1986 May 7;372(2):405-8
3011212
Neuroscience. 2002;109(4):773-8
11927159
Brain Res. 1998 Oct 12;808(1):31-41
9795117
J Comp Neurol. 1999 Sep 6;411(4):683-92
10421877
Am J Physiol. 1996 Jun;270(6 Pt 1):C1726-34
8764156
J Neurosci. 1989 Aug;9(8):2858-65
2549220
Science. 1994 Dec 9;266(5191):1713-7
7527589
Nat Rev Neurosci. 2005 Mar;6(3):215-29
15738957
Alcohol. 2007 May;41(3):201-9
17591543